A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like ...

The American Heart Association and the American Stroke Association updated guidelines for the primary prevention of stroke, ...

Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy ...

Not every company is jumping onto the bandwagon and investing into weight loss drugs, however. One of the largest healthcare ...

There are several types of GLP-1 medications available, each with varying dosing schedules and forms of administration. Some ...

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic.

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

Noom Med with SmartRx, in partnership with Waltz Health, drives significant ROI for employers who wish to cover GLP-1s as a supplemental benefit ...

GLP-1 receptor agonists do not affect cardiovascular, kidney, or safety outcomes regardless of SGLT2 inhibitor use in patients with type 2 diabetes.

VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, announces ...

Transenteric delivery via the RaniPill yielded 80% relative bioavailability versus SC and differences between PK parameters ...